Xijing hospital, Fourth military medical university
Xi'an, Shaanxi, 710032, China
NCT Number: NCT06180876
Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect. It can be used for general anesthesia. However, classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium. Thus, the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Xi'an, Shaanxi, 710032, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
continuous infusion
continuous infusion
Time frame: from end of surgery to 3 days after surgery, in a total of 3 days
Time frame: from extubation of tracheal tube to 30 minutes after extubation, in a total of 30 minutes
Time frame: from end of surgery to 1 day after surgery, in a total of 1 day
Time frame: from end of surgery to response to verbal command, in an average of 10 minutes
Time frame: from start of anesthesia induction to extubation, in an average of 2 hours
hypotension is defined as systolic blood pressure decreasing by more than 20% of baseline value
Time frame: from start of anesthesia induction to extubation, in an average of 2 hours
hypertension is defined as systolic blood pressure increasing by more than 20% of baseline value
Time frame: from end of surgery to 24 hours after surgery, in a total of 24 hours
sleep is monitored by a wrist acti-graphy
Zhihong LU
Other
Effect of General Anesthesia With Remimazolam Versus Propofol on Postoperative Delirium in Elderly Patients
Acronym: RED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05935930
General Anesthetic Drug Adverse Reaction
Damanhūr, El-Beheira, Egypt
View Trial DetailsNCT05468671
Bronchoesophageal Fistula, Endobronchial Metastases
Hanzhou, China
View Trial DetailsNCT04851574
General Anesthetic Drug Adverse Reaction
Poznan, Grand Poland, Poland
View Trial DetailsNCT02617680
General Anesthetic Drug Adverse Reaction
Hradec Králové, Czechia
View Trial Details